We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022
Print article
Image: MagCore EDA - Automated NA Extraction and Smart PCR Setup (Photo courtesy of RBC Bioscience)
Image: MagCore EDA - Automated NA Extraction and Smart PCR Setup (Photo courtesy of RBC Bioscience)

A new instrument launched at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo that combines DNA/RNA extraction and Smart PCR Setup provides a complete solution for lab workflow optimization.

At AACC 2022, RBC Bioscience Corp. (New Taipei City, Taiwan) released its new MagCore EDA which has three modes of operation: NA extraction, PCR setup and NA extraction with PCR setup. MagCore EDA presents a set of unique features such as HEPA filters, cooling plate for idling eluates, spectrophotometer for automatic OD measurements at the end of extraction, safety locks, that ensure the ease of use and safety of the system. The system has features such as PC USB control interface, 1-48 Samples, built-in cooler, HEPA filters, UV decontamination, auto barcode scanner, spectrophotometer, PCR assay setup and serial dilution, LIMS connectivity, and built-in program.

“With the capability of the NA extraction and PCR set up preparation as one operation the instrument provides massive benefits to its users,” said David Cho, CEO of RBC Bioscience Corp. “PCR zone is opened, so the machine can be used by anyone with any kits or reagents they are using, including in-house PCR preparations. Machine passed extensive testing targeting user experience, safety, durability, robustness of the system, pipetting precision and liquid level detection – it is an ultimate solution for most of the mDx users, no matter in research or in clinical market.”

Related Links:
RBC Bioscience Corp. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more